Publications by authors named "Kevin Maggi"

Article Synopsis
  • - Contribution of splicing variants to inherited disease diagnostics is reported to be <10%, likely underestimating their impact due to challenges in prediction, need for functional analysis, and detection issues with existing technologies.
  • - This study aimed to evaluate Nanopore sequencing for identifying and quantifying splicing variants in patients with inherited retinal dystrophies, by using 19 selected candidate variants.
  • - The results showed that 13 of the variants caused abnormal splicing events, and Nanopore sequencing provided a reliable way to identify and quantify these low-abundance transcripts, which traditional methods might miss.
View Article and Find Full Text PDF

The proneural transcription factor atonal basic helix-loop-helix transcription factor 7 () is expressed in early progenitors in the developing neuroretina. In vertebrates, this is crucial for the development of retinal ganglion cells (RGCs), as mutant animals show an almost complete absence of RGCs, underdeveloped optic nerves, and aberrations in retinal vessel development. Human mutations are rare and result in autosomal recessive optic nerve hypoplasia (ONH) or severe vascular changes, diagnosed as autosomal recessive persistent hyperplasia of the primary vitreous (PHPVAR).

View Article and Find Full Text PDF

Basic helix-loop-helix (bHLH) transcription factors are evolutionarily conserved and structurally similar proteins important in development. The temporospatial expression of atonal bHLH transcription factor 7 () directs the differentiation of retinal ganglion cells and mutations in the human gene lead to vitreoretinal and/or optic nerve abnormalities. Characterization of pathogenic mutations is needed to understand the functions of the conserved bHLH motif.

View Article and Find Full Text PDF

The cellular prion protein PrPC is necessary for prion replication, and its reduction greatly increases life expectancy in animal models of prion infection. Hence the factors controlling the levels of PrPC may represent therapeutic targets against human prion diseases. Here we performed an arrayed whole-transcriptome RNA interference screen to identify modulators of PrPC expression.

View Article and Find Full Text PDF